Cole Allen set for court arraignment in WHCD gunfire case
The Secret Service is facing scrutiny over security at the White House Correspondents’ Dinner, where President Donald Trump was evacuated Saturday.
Prediction markets prepare to invade one of crypto’s biggest and riskiest trades
There’s a landgrab underway in the U.S. for perpetual futures, one of the biggest and riskiest parts of crypto — and prediction markets want a piece of it.
OpenAI shakes up partnership with Microsoft, capping revenue share payments
Things have changed since Microsoft and OpenAI announced a broad agreement following OpenAI’s restructuring in October.
Here are Monday’s biggest analyst calls: Nvidia, Apple, Tesla, Micron, AMD, DoorDash, CrowdStrike & more
Here are Monday’s biggest calls on Wall Street.
This bank CEO let his AI clone handle an earnings call — now he’s signing an OpenAI deal
It’s part of Customers Bank CEO Sam Sidhu’s effort to get ahead in the industry’s race to transform itself using AI agents as a new digital workforce
Qualcomm jumps 12% on report it’s partnering with OpenAI on smartphone AI chip
Qualcomm will be working alongside MediaTek to develop a smartphone chip for OpenAI, with manufacturer Luxshare co-designing the device, an analyst said.
MAHA is mad. Its alliance with Trump is about to face its biggest test
Supreme Court arguments Monday and the farm bill put MAHA squarely at odds with President Donald Trump and the majority of Republicans in Congress.
This cybersecurity stock is down sharply in 2026. Jefferies sees a buying opportunity
The investment firm assigned the stock a buy rating.
Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial
Intellia Therapeutics said its Crispr-based treatment for hereditary angioedema met its goals in a Phase 3 trial, marking a milestone for gene editing.
United Airlines CEO confirms he approached American Airlines about merger
Post Content